View in EDS HTML Full Text PDF Full Text

Pharmacological Activation of cGAS for Cancer Immunotherapy.

Saved in:
Bibliographic Details
Title: Pharmacological Activation of cGAS for Cancer Immunotherapy.
Authors: Garland KM; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States., Rosch JC; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States., Carson CS; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States., Wang-Bishop L; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States., Hanna A; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States., Sevimli S; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States., Van Kaer C; Department of Bioengineering, Northeastern University, Boston, MA, United States., Balko JM; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States., Ascano M; Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN, United States., Wilson JT; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, TN, United States.
Source: Frontiers in immunology [Front Immunol] 2021 Nov 26; Vol. 12, pp. 753472. Date of Electronic Publication: 2021 Nov 26 (Print Publication: 2021).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34899704
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pharmacological Activation of cGAS for Cancer Immunotherapy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Garland+KM%22">Garland KM</searchLink>; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Rosch+JC%22">Rosch JC</searchLink>; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Carson+CS%22">Carson CS</searchLink>; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Wang-Bishop+L%22">Wang-Bishop L</searchLink>; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Hanna+A%22">Hanna A</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Sevimli+S%22">Sevimli S</searchLink>; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Van+Kaer+C%22">Van Kaer C</searchLink>; Department of Bioengineering, Northeastern University, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Balko+JM%22">Balko JM</searchLink>; Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Ascano+M%22">Ascano M</searchLink>; Department of Biochemistry, Vanderbilt University Medical Center, Nashville, TN, United States.<br /><searchLink fieldCode="AU" term="%22Wilson+JT%22">Wilson JT</searchLink>; Department of Chemical and Biomolecular Engineering, Vanderbilt University, Nashville, TN, United States.; Department of Biomedical Engineering, Vanderbilt University, Nashville, TN, United States.; Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute for Infection, Immunology, and Inflammation, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Center for Immunobiology, Vanderbilt University Medical Center, Nashville, TN, United States.; Vanderbilt Institute of Chemical Biology, Vanderbilt University Medical Center, Nashville, TN, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2021 Nov 26; Vol. 12, pp. 753472. <i>Date of Electronic Publication: </i>2021 Nov 26 (<i>Print Publication: </i>2021).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34899704
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2021.753472
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 753472
    Titles:
      – TitleFull: Pharmacological Activation of cGAS for Cancer Immunotherapy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Garland KM
      – PersonEntity:
          Name:
            NameFull: Rosch JC
      – PersonEntity:
          Name:
            NameFull: Carson CS
      – PersonEntity:
          Name:
            NameFull: Wang-Bishop L
      – PersonEntity:
          Name:
            NameFull: Hanna A
      – PersonEntity:
          Name:
            NameFull: Sevimli S
      – PersonEntity:
          Name:
            NameFull: Van Kaer C
      – PersonEntity:
          Name:
            NameFull: Balko JM
      – PersonEntity:
          Name:
            NameFull: Ascano M
      – PersonEntity:
          Name:
            NameFull: Wilson JT
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 26
              M: 11
              Text: 2021 Nov 26
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 12
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1